Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
What happened today?
Finally, some volume.It is nice to see that we are trading the stock of this company.Any forthcoming news that anybody wants to share. please post if you know why the stock is moving today.
if end of the week VL presentation positive I think this company should worth at least 100 million usd or 4x today share price
Do you think this thing is done selling? Showing us a buy signal now on VICL? if you guys have questions you should ask awesom-eSTOCKS. They often respond to my emails which is helpful.
I turn positive on vical. so many iron rods in the fire. if any turn positive it will make a tremendous comeback. I think they have a good shot specially on herpes and fungus. also that anges collaboration must have some legs.
Candida auris is an emerging fungus that presents a serious global health threat. C. auris is a drug resistant strain of fungus fatal 60% of the time in humans. It can survive for weeks on surfaces and for months on your skin. It is showing up in U.S. hospitals at an increasing rate and there are no anti-fungals to treat it. VL-2397 has a unique mechanism to attack fungi that are resistant to the other anti-fungals and could turn out to be our only hope.
Vical announced an update of HSV-2 and antifungal programs during Research & Development Day on Tuesday, May 2, 2017.
Received an alert this am about $VICL from http://yugestocks.com/?s=VICL, you may want to take a look. Making money investing. Hutchins' law: you can't out-talk a man who knows what he's talking about.
Yuge Stocks: Trading Stocks and Making Money
Stock alerts from the Yuge Stocks. Stock trading, making money and always looking for the next big money maker.
Vical has completed the enrollment Phase 2 HSV-2 vaccine.
Original paid in capital and surplus $459 million vs $23.3 million current market cap ( selling now for 5 cents on the dollar) well what is next?????
Anges reported 100% life sparing effectiveness using their equine antibodies in Ebola infected mice.There may be no limit to how many diseases equine antibodies could end up treating....malaria?....cancer? Reuters says Anges and Vical have agreed to protect IP rights so expect some new patent applications soon.
Anges announced the development of gene therapy drug for the treatment of chronic hepatitis B in cooperation with Vical.
Low float & high volume. The chart looks strong if it pick up more vol pm it's breaking $4.
The upside potential for VICL just got a whole lot more interesting. This is so frustrating trying to find trade ideas. I've subscribed to some email newsletters which helps me with new stock ideas. a.awesomestocks is the one i like best.
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.8 In other words, the correlation coefficient of the other stoc